By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Znomics, Inc. 

2611 SW 3rd Avenue
Suite 200
Portland  Oregon  97201  U.S.A.
Phone: 503-827-5271 Fax: 503-228-3290



Drug Discovery

Company News
Znomics, Inc. Announces Purchase of $50,000 of Its Common Stock by Directors and Officers 10/13/2008 9:41:17 AM
Znomics, Inc. Builds Patent Estate for Proprietary Zebrafish Technologies 10/13/2008 9:39:27 AM
Znomics, Inc. Appoints Ofir Moreno, Ph.D., as Senior Director of Chemistry 8/25/2008 9:26:36 AM
Znomics, Inc. Appoints Mark. A. Philip, Ph.D., as New President and Chief Executive Officer 8/15/2008 7:56:28 AM
Znomics, Inc. Registration Statement Becomes Effective 8/11/2008 12:12:09 PM
Znomics, Inc. Appoints Charles N. Blitzer to Board of Directors 7/15/2008 9:10:53 AM
Znomics, Inc. and Leading Chemist At Oregon Health & Science University (OHSU) Launch Drug Discovery Program for Treatment of Inflammatory Diseases 7/9/2008 8:46:45 AM
Znomics, Inc. Appoints Pharmaceutical Drug Discovery Expert, Bruce A. Beutel, Ph.D., as New Chief Scientific Officer 6/11/2008 10:11:24 AM
Znomics, Inc. to Hold Business Strategy Conference Call May 22, 2008 5/14/2008 11:42:52 AM
Znomics, Inc. and University of Utah Launch Collaborative Drug Discovery Program in Oncology, Autoimmune Disease and Inflammation 5/9/2008 10:45:02 AM